Quote from 18 days ago June 4th:

“I'm back on the cho cho train lol!. And I can absolutely promise you I have not bought any shares the past 2 days other than 170 K the other day at .082. And when you have over 5 M that really makes no difference.

However I do think 4 things have turned me around.

They actually hired an IR person. Great step.

Ox's post.

Chart and buying says support at .08...as it should.

Finally I emailed my contact out of NYC this afternoon and he responded with one phrase....Bombs incoming.

I can only take that as a good thing.

As to the other post about the financing and the news after the N and S change. I for sure was not the only one 'given' that impression, but I was very outspoken about that. I own up to that.

Only thing I can say is I hope something came along (deals) that delayed that.”


Do recent posts mean you are now off the choo choo train that you got back onto 18 days ago? You get on and off the train frequently.

People need to stop throwing darts at boards. This will move when there is material news. Period. Market makers will pull it back and some people will sell. I added today.

I believe any cash on hand is to keep thing moving forward, paying the bills etc. Don’t think they have any cash for a material stock buy back. Stock buy back will not happen here.

For sure. How can that possibly happen when their goal is to get the IND submitted by the end of the year for Metformin which is the primary focus and best short term solution.

Best to do one’s own due diligence, know what you own and not listen to the noise. Manipulators lurk around every turn. So many contradictory posts from one day to the next.

Can’t help but wonder what the epic part of the meeting. Seemed like there was going to be more come out from the meeting. Maybe epic because he just bought Paul was awesome?

Spoke with the new IR person today. Very informative. Bottom line is that the potential market for repurposing Metformin into an eye drop is huge, $20-30B with dry and wet combined. Goal is to submit IND by end of year, then be in a combined phase 1 and 2 combo six months later which is actually a very short time frame. Combined 1 and 2 because they won’t have to go through as extensive safety trials since Metformin has been on the market for a long time as the number one treatment for diabetes. It is very safe. Diabetes patients being treated by Metformin have not only showed signs of slowing the aging process but also had less of a chance of getting eye disease. Good things ahead. Under a dime is a gift.

P/E ratio at this point means very little. Earnings come from revenue. They are in the development stage so revenues will come down steam. They have virtually no revenues at this point which is to be expected, so the P/E ratio is not a material metric.

Welcome back! Where did you see they hired a IR guy? That is indeed good news.

Great information! I seriously doubt Paul sits behind his desk each day wondering when he is going to be able to sell his shares. And people who start a business like this typically maintain a controlling interest in the company (along with a lot of shares) so they can make the business decisions they think are needed to take it where they want to go. It is the way business works. Success will make them rich, of course. As for me I don’t care how much money these guys make. It they build what many of us think they can build we will all benefit. Again great due diligence on the share research.

I’d say people really want out is a stretch. On average it trades 2 tenths of one percent of its O/S on a daily basis. There is very little volume daily relative to O/S. This is a classic case of the market makers walking this thing down day by day on low volume in between news cycles and at a time when the OTC overall has taken a beating. Material news will get it going again. The question is what will the news be and when does that happen. There is no liquidity from volume. Liquidity will hit on news and it will happen fast. All in my opinion of course having followed this stock since Paul took it over.

Is there an OTC company that wouldn’t drop over 50% or more if they did not release any news for the next several months? Nope. None. I would expect them to have news before this time frame. When? God only knows.

Or perhaps get into a partnership w another company.

Good points once again. I will keep in touch with Paul directly though. There are no other options and I would rather risk that relationship clouding my views than not have a direct link to the company, especially since they do not do PR’s with much frequency. If I have questions which I do I prefer to hear it straight from the horse’s mouth.

You’re right, you don’t know.

You should call Paul the Chairman and ask him, if you have not already. It is not uncommon for companies to delay filings and it is for only five days. I personally expect the 10Q by the end of the week.

No doubt they could benefit kids and anyone else who has bone cancer. CycloSam is being developed by the same two people who developed Quadramet. However, my understanding from the company investor deck is that it is 40x less harmful or toxic to the body as Quadramet is. So that should be well received by the FDA. Glad you reached out to David. He seems like a good IR guy to have in our corner.

You make some good points here. Paul’s approach has been the same though from the time the stock went from under a penny to .20 as it is now. It has obviously pulled back since then as it did on other prior runs, plus OTC in general has taken a beating. With the right news it will move again. I am sure he will report the news when it happens. I for one like his accessibility to shareholders. I like getting questions answered straight from the horse’s mouth. I have found I get more quality information from business leaders than I have from IR firms. All this just my opinion. Good luck to all longs.

Thanks for the input. Good to hear. Is your daughter familiar with various cancer treatments? What blew her away by the med?

That’s interesting because I am up 200%. And I know other are up 1k % plus as early investors.

If you have any questions, recommend reaching out to him directly. He is very responsive. I was the first investor to have reached out to him.

IMO a share buy back is the last thing they should be doing right now. They have enough cash to fund operations for a 24 month runway according to Ken. Any and all money should be devoted to building their businesses, their platforms, driving traffic to the platforms, getting relevant content for the platforms and getting the three companies to their liquidity events. Anything else is a waste of time and resources. All my opinion of course. They’ll get it done.

Not true. Watch the podcast. Ken addressed this question.

Nice digging F2. You flushed him out. Did the $99 office give it away?

Had some back and forth email communication with the President and CEO of the firm now leading Investor Relations for QSAM, the man whose name now appears on the Press Releases. Was very impressed with the timing of his response and the in depth answers to my questions. In short the thing he said that struck me the most was that given his extensive experience in IR and financial banking (which is vast) he has to really believe in a company before they get involved. Never been more confident in my investment.

The next podcast is May 17th. The 8K you posted showed the old schedule and the new schedule. New schedule shows May 17th.

Totally agree.

If he has 20M shares he’s had them all the way up to .20. I am not concerned about this.

Delaying what?

This is actually getting comical.

Adding more shares today sub $.12.

#4 post:

CUBT has an Exclusive Patent License Agreement to repurpose the use of Metformin, one of the most prescribed drugs in the world, to treat Retinal Degeneration (RD), one of the biggest causes of blindness in the elderly. The agreements are listed with the Federal Government’s National Eye Institute (NEI), an arm of the National Institutes of Health (NIH).

CUBT has also hired Dr. Kapil Bharti, the lead inventor on all of the licensed patents (pending) from NEI at NIH, onto its Scientific and Clinical Advisory Board to help guide the program. His expertise and insights will be invaluable. I don’t think he would be putting his reputation on the line if he was say, only a mantle piece.

This is kind of company I can get behind as they develop their product pipeline working in a financially responsible way without having a corporate office, which we all know costs money.

There are a number of filings out there. Can you post the link to it to save us some time so we can address your question?

I believe they can IPO prior but the company has made the business decision not to until that time, which I personally agree with. And Ken has stated as such.

Horn must have sounded and he probably “clocked out” for the day. Or he is on a lunch break in an overseas sweat shop. His language and word choice sounds like that is where he works.

This is the kind of “disaster” I can get on board with. What a great rebound. My time horizon is months, not days.

Unless there is a connection between the two that we are not yet aware of. I am not familiar with the company but interesting that CCAJ is up100% today.

Sorry make that CCAJ. I’m old.

Anyone know the significance of Ginsberg joining AACJ (Capital Coastal Acquisition) as a Consultant? These guys are up to something.

I have bid in right now for 10K for .1172. Ask is .117. Not hitting. Manipulation!! Hey “buy signal” man tell your boys to give me my shares. They are manipulators.